Alogliptin: a new addition to the class of DPP-4 inhibitors

BACKGROUND: Alogliptin is an oral antihyperglycemic agent that is a selective inhibitor of the enzyme dipeptidyl peptidase-4 (DPP-4). Inhibition of DPP-4 elevates levels of the incretin hormones glucagon-like peptide (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) by preventing their...

Descripción completa

Detalles Bibliográficos
Autores principales: Andukuri, Radha, Drincic, Andjela, Rendell, Marc
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048010/
https://www.ncbi.nlm.nih.gov/pubmed/21437125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048010/
https://www.ncbi.nlm.nih.gov/pubmed/21437125

Ejemplares similares